Systematic Evaluation of the Predictive Importance of Tumor Cell Content Indicators of Endoscopic Samples for Molecular Examinations in Patients with NSCLC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017152

Enrollment

Registered

2019-07-22

Start date

2018-12-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: Single Arm Study, endobronchial ultrasound in the context of tumor diagnostics, sample processing in pathology, retrospective sample evaluation as result of the study

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Inclusion criteria

Inclusion criteria: NSCLC Stage IV

Exclusion criteria

Exclusion criteria: Contraindication Rigid Bronchoscopy / EBUS

Design outcomes

Primary

Measure	Time frame
The aim of the project is to identify tumor cell content indicators of endoscopic NSCLC samples as part of the sampling process in order to ensure a successful molecular analysis of the necessary biomarkers.	—

Secondary

Measure	Time frame
Sample weight, complications and macroscopic assessment	—

Countries

Germany

Contacts

Public ContactBirte Schwarz

Ruhrlandklinik

birte.schwarz@uk-essen.de00492014330

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026